Does topical hemostatic agent (Floseal®) have a long-term adverse effect on erectile function recovery after nerve-sparing robot-assisted radical prostatectomy?

Eugenio MartoranaBernardo RoccoShaniko KaleciGiacomo Maria PirolaLuigi BevilacquaLuca Reggiani BonettiStefano PuliattiSalvatore MicaliGiampaolo Bianchi

Published in: International urology and nephrology (2017)

The results of our study suggest that local use of Floseal® worsens the long-term erectile function recovery in patients selected for nerve-sparing RALP.

Keyphrases

robot assisted
radical prostatectomy
prostate cancer
minimally invasive
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
benign prostatic hyperplasia
emergency department